6th Biennial Conference of the American Society of Health Economists

June 12 - 15, 2016

Topics in Pharmaceutical Regulation

This session will explore multiple topics on the subject of pharmaceutical regulation. One paper will discuss the relationship between expedited approval programs and post-market safety events. A second paper will use FDA designations to construct an index to measure pharmaceutical innovation. The final paper presents a case for the efficacy standard in FDA approvals.